Cargando…

Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch

BACKGROUND: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma. CASE PRESENTATION: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical live...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hiromichi, Kobayashi, Takuma, Kudou, Michihiro, Nishimura, Masumi, Toma, Atsushi, Nakamura, Kenji, Mazaki, Takeshi, Itoh, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275512/
https://www.ncbi.nlm.nih.gov/pubmed/22273493
http://dx.doi.org/10.1186/1477-7819-10-22
_version_ 1782223226144817152
author Ishii, Hiromichi
Kobayashi, Takuma
Kudou, Michihiro
Nishimura, Masumi
Toma, Atsushi
Nakamura, Kenji
Mazaki, Takeshi
Itoh, Tsuyoshi
author_facet Ishii, Hiromichi
Kobayashi, Takuma
Kudou, Michihiro
Nishimura, Masumi
Toma, Atsushi
Nakamura, Kenji
Mazaki, Takeshi
Itoh, Tsuyoshi
author_sort Ishii, Hiromichi
collection PubMed
description BACKGROUND: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma. CASE PRESENTATION: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely. Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2 portal branch. No postoperative liver failure occurred, and remnant liver function was adequate. CONCLUSION: The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be considered for a patient with a liver tumor located at segment 2 arising from a damaged liver.
format Online
Article
Text
id pubmed-3275512
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32755122012-02-09 Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch Ishii, Hiromichi Kobayashi, Takuma Kudou, Michihiro Nishimura, Masumi Toma, Atsushi Nakamura, Kenji Mazaki, Takeshi Itoh, Tsuyoshi World J Surg Oncol Technical Innovations BACKGROUND: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma. CASE PRESENTATION: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely. Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2 portal branch. No postoperative liver failure occurred, and remnant liver function was adequate. CONCLUSION: The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be considered for a patient with a liver tumor located at segment 2 arising from a damaged liver. BioMed Central 2012-01-25 /pmc/articles/PMC3275512/ /pubmed/22273493 http://dx.doi.org/10.1186/1477-7819-10-22 Text en Copyright ©2012 Ishii et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Innovations
Ishii, Hiromichi
Kobayashi, Takuma
Kudou, Michihiro
Nishimura, Masumi
Toma, Atsushi
Nakamura, Kenji
Mazaki, Takeshi
Itoh, Tsuyoshi
Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
title Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
title_full Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
title_fullStr Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
title_full_unstemmed Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
title_short Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
title_sort anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
topic Technical Innovations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275512/
https://www.ncbi.nlm.nih.gov/pubmed/22273493
http://dx.doi.org/10.1186/1477-7819-10-22
work_keys_str_mv AT ishiihiromichi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT kobayashitakuma anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT kudoumichihiro anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT nishimuramasumi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT tomaatsushi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT nakamurakenji anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT mazakitakeshi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch
AT itohtsuyoshi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch